Last reviewed · How we verify
Normal control
At a glance
| Generic name | Normal control |
|---|---|
| Sponsor | Janssen Korea, Ltd., Korea |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effect of Lidocaine Infusion Versus Dexmedemidine Infusion on the Neurocognitive Function of Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography(ERCP): a Randomized, Controlled Trial. (NA)
- Immediate Restoration of a New Implant With High Primary Stability (NA)
- The Effectiveness of Neurodevelopmental Treatment (Bobath) and Functional Physiotherapy in Children With Cerebral Palsy. (NA)
- Blood Collection to Validated New Therapeutics Strategies Against Preeclampsia
- Effect of Kinesio Taping Application in Addition to Pilates Exercises on Core Muscle Thickness, Cognition and Mental Fatigue in Individuals With Non-specific Low Back Pain (NA)
- Top-Down Attentional Control of Visual-Processing
- Effects of Positive Psychological Group Psychotherapy and Auricular Acupressure on Withdrawal Symptoms (NA)
- USC-Exos in Corpus Spongiosum Reconstruction for Hypospadias (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Normal control CI brief — competitive landscape report
- Normal control updates RSS · CI watch RSS
- Janssen Korea, Ltd., Korea portfolio CI